In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.
NYT > World News
In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.NYT > World News